These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
507 related items for PubMed ID: 20398351
1. The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial. Shakur H, Elbourne D, Gülmezoglu M, Alfirevic Z, Ronsmans C, Allen E, Roberts I. Trials; 2010 Apr 16; 11():40. PubMed ID: 20398351 [Abstract] [Full Text] [Related]
2. The effect of tranexamic acid on the risk of death and hysterectomy in women with post-partum haemorrhage: statistical analysis plan for the WOMAN trial. Shakur H, Roberts I, Edwards P, Elbourne D, Alfirevic Z, Ronsmans C. Trials; 2016 May 17; 17(1):249. PubMed ID: 27188698 [Abstract] [Full Text] [Related]
3. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. WOMAN Trial Collaborators. Lancet; 2017 May 27; 389(10084):2105-2116. PubMed ID: 28456509 [Abstract] [Full Text] [Related]
4. Antifibrinolytic drugs for treating primary postpartum haemorrhage. Shakur H, Beaumont D, Pavord S, Gayet-Ageron A, Ker K, Mousa HA. Cochrane Database Syst Rev; 2018 Feb 20; 2(2):CD012964. PubMed ID: 29462500 [Abstract] [Full Text] [Related]
5. Tranexamic acid for the prevention of postpartum bleeding in women with anaemia: study protocol for an international, randomised, double-blind, placebo-controlled trial. Ker K, Roberts I, Chaudhri R, Fawole B, Beaumont D, Balogun E, Prowse D, Pepple T, Javaid K, Kayani A, Arulkumaran S, Bates I, Shakur-Still H, WOMAN-2 trial collaborators. Trials; 2018 Dec 29; 19(1):712. PubMed ID: 30594227 [Abstract] [Full Text] [Related]
6. HALT-IT--tranexamic acid for the treatment of gastrointestinal bleeding: study protocol for a randomised controlled trial. Roberts I, Coats T, Edwards P, Gilmore I, Jairath V, Ker K, Manno D, Shakur H, Stanworth S, Veitch A. Trials; 2014 Nov 19; 15():450. PubMed ID: 25409738 [Abstract] [Full Text] [Related]
7. Therapeutic and pharmaco-biological, dose-ranging multicentre trial to determine the optimal dose of TRAnexamic acid to reduce blood loss in haemorrhagic CESarean delivery (TRACES): study protocol for a randomised, double-blind, placebo-controlled trial. Bouthors AS, Hennart B, Jeanpierre E, Baptiste AS, Saidi I, Simon E, Lannoy D, Duhamel A, Allorge D, Susen S. Trials; 2018 Mar 01; 19(1):148. PubMed ID: 29490682 [Abstract] [Full Text] [Related]
8. The impact of early outcome events on the effect of tranexamic acid in post-partum haemorrhage: an exploratory subgroup analysis of the WOMAN trial. Brenner A, Shakur-Still H, Chaudhri R, Fawole B, Arulkumaran S, Roberts I, WOMAN Trial Collaborators. BMC Pregnancy Childbirth; 2018 Jun 07; 18(1):215. PubMed ID: 29879947 [Abstract] [Full Text] [Related]
9. Tranexamic acid for acute gastrointestinal bleeding (the HALT-IT trial): statistical analysis plan for an international, randomised, double-blind, placebo-controlled trial. Brenner A, Afolabi A, Ahmad SM, Arribas M, Chaudhri R, Coats T, Cuzick J, Gilmore I, Hawkey C, Jairath V, Javaid K, Kayani A, Mutti M, Nadeem MA, Shakur-Still H, Stanworth S, Veitch A, Roberts I, HALT-IT Trial Collaborators. Trials; 2019 Jul 30; 20(1):467. PubMed ID: 31362765 [Abstract] [Full Text] [Related]
10. Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT. Sprigg N, Flaherty K, Appleton JP, Al-Shahi Salman R, Bereczki D, Beridze M, Ciccone A, Collins R, Dineen RA, Duley L, Egea-Guerrero JJ, England TJ, Karlinski M, Krishnan K, Laska AC, Law ZK, Ovesen C, Ozturk S, Pocock SJ, Roberts I, Robinson TG, Roffe C, Peters N, Scutt P, Thanabalan J, Werring D, Whynes D, Woodhouse L, Bath PM. Health Technol Assess; 2019 Jul 30; 23(35):1-48. PubMed ID: 31322116 [Abstract] [Full Text] [Related]
11. TRAAP2 - TRAnexamic Acid for Preventing postpartum hemorrhage after cesarean delivery: a multicenter randomized, doubleblind, placebo- controlled trial - a study protocol. Sentilhes L, Daniel V, Deneux-Tharaux C, TRAAP2 Study Group and the Groupe de Recherche en Obstétrique et Gynécologie (GROG). BMC Pregnancy Childbirth; 2020 Jan 31; 20(1):63. PubMed ID: 32005192 [Abstract] [Full Text] [Related]
12. Tranexamic acid in the routine treatment of postpartum hemorrhage in the United States: a cost-effectiveness analysis. Sudhof LS, Shainker SA, Einerson BD. Am J Obstet Gynecol; 2019 Sep 31; 221(3):275.e1-275.e12. PubMed ID: 31226298 [Abstract] [Full Text] [Related]
13. Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial. HALT-IT Trial Collaborators. Lancet; 2020 Jun 20; 395(10241):1927-1936. PubMed ID: 32563378 [Abstract] [Full Text] [Related]
14. Prophylactic tranexamic acid for reducing intraoperative blood loss during cesarean section in women at high risk of postpartum hemorrhage: A double-blind placebo randomized controlled trial. Ortuanya KE, Eleje GU, Ezugwu FO, Odugu BU, Ikechebelu JI, Ugwu EO, Eke AC, Awkadigwe FI, Ezenwaeze MN, Ofor IJ, Okafor CC, Okafor CG. Womens Health (Lond); 2024 Jun 20; 20():17455057231225311. PubMed ID: 38279808 [Abstract] [Full Text] [Related]
15. Study protocol. TRAAP - TRAnexamic Acid for Preventing postpartum hemorrhage after vaginal delivery: a multicenter randomized, double-blind, placebo-controlled trial. Sentilhes L, Daniel V, Darsonval A, Deruelle P, Vardon D, Perrotin F, Le Ray C, Senat MV, Winer N, Maillard F, Deneux-Tharaux C. BMC Pregnancy Childbirth; 2015 Jun 14; 15():135. PubMed ID: 26071040 [Abstract] [Full Text] [Related]
16. A high-dose 24-hour tranexamic acid infusion for the treatment of significant gastrointestinal bleeding: HALT-IT RCT. Roberts I, Shakur-Still H, Afolabi A, Akere A, Arribas M, Austin E, Bal K, Bazeer N, Beaumont D, Brenner A, Carrington L, Chaudhri R, Coats T, Gilmore I, Halligan K, Hussain I, Jairath V, Javaid K, Kayani A, Lisman T, Mansukhani R, Miners A, Mutti M, Nadeem MA, Pollok R, Prowse D, Simmons J, Stanworth S, Veitch A, Williams J. Health Technol Assess; 2021 Oct 14; 25(58):1-86. PubMed ID: 34663491 [Abstract] [Full Text] [Related]
17. Protocol for a pilot, randomised, double-blinded, placebo-controlled trial of prophylactic use of tranexamic acid for preventing postpartum haemorrhage (TAPPH-1). Alam A, Bopardikar A, Au S, Barrett J, Callum J, Kiss A, Choi S. BMJ Open; 2017 Oct 11; 7(10):e018586. PubMed ID: 29025850 [Abstract] [Full Text] [Related]
18. The effect of prophylactic intravenous tranexamic acid on blood loss after vaginal delivery in women at low risk of postpartum haemorrhage: a double-blind randomised controlled trial. Mirghafourvand M, Mohammad-Alizadeh S, Abbasalizadeh F, Shirdel M. Aust N Z J Obstet Gynaecol; 2015 Feb 11; 55(1):53-8. PubMed ID: 25688820 [Abstract] [Full Text] [Related]
19. Tranexamic Acid for the Prevention of Blood Loss after Cesarean Delivery. Sentilhes L, Sénat MV, Le Lous M, Winer N, Rozenberg P, Kayem G, Verspyck E, Fuchs F, Azria E, Gallot D, Korb D, Desbrière R, Le Ray C, Chauleur C, de Marcillac F, Perrotin F, Parant O, Salomon LJ, Gauchotte E, Bretelle F, Sananès N, Bohec C, Mottet N, Legendre G, Letouzey V, Haddad B, Vardon D, Madar H, Mattuizzi A, Daniel V, Regueme S, Roussillon C, Benard A, Georget A, Darsonval A, Deneux-Tharaux C, Groupe de Recherche en Obstétrique et Gynécologie. N Engl J Med; 2021 Apr 29; 384(17):1623-1634. PubMed ID: 33913639 [Abstract] [Full Text] [Related]
20. Tranexamic Acid for the Prevention of Blood Loss after Vaginal Delivery. Sentilhes L, Winer N, Azria E, Sénat MV, Le Ray C, Vardon D, Perrotin F, Desbrière R, Fuchs F, Kayem G, Ducarme G, Doret-Dion M, Huissoud C, Bohec C, Deruelle P, Darsonval A, Chrétien JM, Seco A, Daniel V, Deneux-Tharaux C, Groupe de Recherche en Obstétrique et Gynécologie. N Engl J Med; 2018 Aug 23; 379(8):731-742. PubMed ID: 30134136 [Abstract] [Full Text] [Related] Page: [Next] [New Search]